These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 7961651

  • 1. Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities.
    Jenkins CM, Waterman MR.
    J Biol Chem; 1994 Nov 04; 269(44):27401-8. PubMed ID: 7961651
    [Abstract] [Full Text] [Related]

  • 2. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
    Jenkins CM, Waterman MR.
    Biochemistry; 1998 Apr 28; 37(17):6106-13. PubMed ID: 9558349
    [Abstract] [Full Text] [Related]

  • 3. The function of recombinant cytochrome P450s in intact Escherichia coli cells: the 17 alpha-hydroxylation of progesterone and pregnenolone by P450c17.
    Shet MS, Fisher CW, Estabrook RW.
    Arch Biochem Biophys; 1997 Mar 01; 339(1):218-25. PubMed ID: 9056252
    [Abstract] [Full Text] [Related]

  • 4. Negatively charged anabaena flavodoxin residues (Asp144 and Glu145) are important for reconstitution of cytochrome P450 17alpha-hydroxylase activity.
    Jenkins CM, Genzor CG, Fillat MF, Waterman MR, Gómez-Moreno C.
    J Biol Chem; 1997 Sep 05; 272(36):22509-13. PubMed ID: 9278403
    [Abstract] [Full Text] [Related]

  • 5. Escherichia coli flavodoxin sepharose as an affinity resin for cytochromes P450 and use to identify a putative cytochrome P450c17/3beta-hydroxysteroid dehydrogenase interaction.
    Jenkins CM, Pikuleva I, Kagawa N, Waterman MR.
    Arch Biochem Biophys; 1997 Nov 01; 347(1):93-102. PubMed ID: 9344469
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS, Yamazaki H, Guo Z, Guengerich FP.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):11-9. PubMed ID: 8615680
    [Abstract] [Full Text] [Related]

  • 7. P450BM-3; a tale of two domains--or is it three?
    Peterson JA, Sevrioukova I, Truan G, Graham-Lorence SE.
    Steroids; 1997 Jan 01; 62(1):117-23. PubMed ID: 9029725
    [Abstract] [Full Text] [Related]

  • 8. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
    Bonants PJ, Müller F, Vervoort J, Edmondson DE.
    Eur J Biochem; 1990 Jul 05; 190(3):531-7. PubMed ID: 2115440
    [Abstract] [Full Text] [Related]

  • 9. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
    Estabrook RW, Shet MS, Fisher CW, Jenkins CM, Waterman MR.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):308-15. PubMed ID: 8806785
    [Abstract] [Full Text] [Related]

  • 10. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
    Gruez A, Pignol D, Zeghouf M, Covès J, Fontecave M, Ferrer JL, Fontecilla-Camps JC.
    J Mol Biol; 2000 May 26; 299(1):199-212. PubMed ID: 10860732
    [Abstract] [Full Text] [Related]

  • 11. The flavoprotein component of the Escherichia coli sulfite reductase can act as a cytochrome P450c17 reductase.
    Zeghouf M, Defaye G, Fontecave M, Coves J.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):602-5. PubMed ID: 9618257
    [Abstract] [Full Text] [Related]

  • 12. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase.
    Lin D, Black SM, Nagahama Y, Miller WL.
    Endocrinology; 1993 Jun 29; 132(6):2498-506. PubMed ID: 8504753
    [Abstract] [Full Text] [Related]

  • 13. Expression in Escherichia coli of functional cytochrome P450c17 lacking its hydrophobic amino-terminal signal anchor.
    Sagara Y, Barnes HJ, Waterman MR.
    Arch Biochem Biophys; 1993 Jul 29; 304(1):272-8. PubMed ID: 8323292
    [Abstract] [Full Text] [Related]

  • 14. The three-dimensional structure of flavodoxin reductase from Escherichia coli at 1.7 A resolution.
    Ingelman M, Bianchi V, Eklund H.
    J Mol Biol; 1997 Apr 25; 268(1):147-57. PubMed ID: 9149148
    [Abstract] [Full Text] [Related]

  • 15. Characterisation of flavodoxin NADP+ oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli.
    McIver L, Leadbeater C, Campopiano DJ, Baxter RL, Daff SN, Chapman SK, Munro AW.
    Eur J Biochem; 1998 Nov 01; 257(3):577-85. PubMed ID: 9839946
    [Abstract] [Full Text] [Related]

  • 16. Preparation and properties of a cross-linked complex between ferredoxin--NADP+ reductase and flavodoxin.
    Pueyo JJ, Sancho J, Edmondson DE, Gómez-Moreno C.
    Eur J Biochem; 1989 Aug 15; 183(3):539-44. PubMed ID: 2506011
    [Abstract] [Full Text] [Related]

  • 17. Routes of flavodoxin and ferredoxin reduction in Escherichia coli. CoA-acylating pyruvate: flavodoxin and NADPH: flavodoxin oxidoreductases participating in the activation of pyruvate formate-lyase.
    Blaschkowski HP, Neuer G, Ludwig-Festl M, Knappe J.
    Eur J Biochem; 1982 Apr 15; 123(3):563-9. PubMed ID: 7042345
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the 17 alpha-hydroxylase/C17,20-lyase activities of porcine, guinea pig and bovine P450c17 using purified recombinant fusion proteins containing P450c17 linked to NADPH-P450 reductase.
    Shet MS, Fisher CW, Tremblay Y, Belanger A, Conley AJ, Mason JI, Estabrook RW.
    Drug Metab Rev; 2007 Apr 15; 39(2-3):289-307. PubMed ID: 17786622
    [Abstract] [Full Text] [Related]

  • 19. Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency.
    Imai T, Globerman H, Gertner JM, Kagawa N, Waterman MR.
    J Biol Chem; 1993 Sep 15; 268(26):19681-9. PubMed ID: 8396144
    [Abstract] [Full Text] [Related]

  • 20. Progesterone metabolism in recombinant yeast simultaneously expressing bovine cytochromes P450c17 (CYP17A1) and P450c21 (CYP21B1) and yeast NADPH-P450 oxidoreductase.
    Sakaki T, Akiyoshi-Shibata M, Yabusaki Y, Manabe K, Murakami H, Ohkawa H.
    Pharmacogenetics; 1991 Nov 15; 1(2):86-93. PubMed ID: 1844874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.